Hereditary spastic paraplegia: genes and variants
Explore variant evidence for Hereditary spastic paraplegia across 15 analyzed proteins (SPAST, ATL1, KIF1A, KIF5A, SPG7 and 10 more). Linked ClinVar records include 336 pathogenic or likely pathogenic variants, 1,818 variants of uncertain significance and 379 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hereditary spastic paraplegia
SPAST: Spastin
It severs microtubules and remodels the axonal cytoskeleton, enabling organelle transport and maintenance of very long corticospinal axons. Dominant loss-of-function variants are the most common cause of hereditary spastic paraplegia, classically SPG4.
139 ClinVar pathogenic / likely pathogenic and 262 uncertain variants in SPAST have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
ATL1: Atlastin-1
It promotes homotypic fusion of endoplasmic-reticulum membranes and is required for normal organization of the tubular ER network, especially in long axons. Dominant pathogenic variants are a common cause of hereditary spastic paraplegia type 3A.
50 ClinVar pathogenic / likely pathogenic and 192 uncertain variants in ATL1 have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
KIF1A: Kinesin-like protein KIF1A
It transports synaptic vesicle precursors and other cargo along axonal microtubules toward nerve terminals. Pathogenic variants cause a broad KIF1A-associated neurological disorder spectrum including hereditary sensory neuropathy, spastic paraplegia, optic atrophy, ataxia, and developmental impairment.
44 ClinVar pathogenic / likely pathogenic and 300 uncertain variants in KIF1A have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
KIF5A: Kinesin heavy chain isoform 5A
It drives anterograde transport of organelles and proteins along axonal microtubules and is especially important in long motor neurons. Pathogenic variants can cause hereditary spastic paraplegia, axonal Charcot-Marie-Tooth disease, or amyotrophic lateral sclerosis depending on the affected region and mechanism.
32 ClinVar pathogenic / likely pathogenic and 421 uncertain variants in KIF5A have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
SPG7: Mitochondrial inner membrane m-AAA protease component paraplegin
It participates in mitochondrial inner-membrane protein quality control and respiratory homeostasis as part of the m-AAA protease machinery. Biallelic pathogenic variants cause SPG7-related disease, commonly presenting with spastic ataxia, optic neuropathy, or progressive gait impairment.
27 ClinVar pathogenic / likely pathogenic and 311 uncertain variants in SPG7 have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
PLP1: Myelin proteolipid protein
It supports central-nervous-system myelin structure and is required for oligodendrocyte and axonal integrity. Gene duplication most commonly causes Pelizaeus-Merzbacher disease, while other variants can cause spastic paraplegia type 2 or milder leukodystrophy.
14 ClinVar pathogenic / likely pathogenic and 57 uncertain variants in PLP1 have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
L1CAM: Neural cell adhesion molecule L1
It promotes neuronal adhesion, axon guidance, neurite growth, and fasciculation during nervous-system development. Loss-of-function variants cause L1 syndrome, encompassing X-linked hydrocephalus, MASA syndrome, spastic paraplegia, and variable intellectual disability.
13 ClinVar pathogenic / likely pathogenic and 172 uncertain variants in L1CAM have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
REEP1: Receptor expression-enhancing protein 1
It shapes tubular endoplasmic-reticulum membranes and supports interactions between the ER and neuronal cytoskeleton, particularly in long corticospinal axons. Pathogenic variants are a common cause of hereditary spastic paraplegia type 31 and can occasionally produce distal motor neuropathy.
12 ClinVar pathogenic / likely pathogenic and 98 uncertain variants in REEP1 have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
ATP13A2: Polyamine-transporting ATPase 13A2
It supports lysosomal and endolysosomal homeostasis and transports polyamines and other cationic substrates across intracellular membranes. Biallelic pathogenic variants cause Kufor-Rakeb syndrome and related early-onset parkinsonian-neurodegenerative phenotypes.
2 ClinVar pathogenic / likely pathogenic and 350 uncertain variants in ATP13A2 have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
FGG: Fibrinogen gamma chain
It contributes the gamma chains of fibrinogen and provides binding sites important for fibrin polymerization, platelet interactions, and clot stabilization. Pathogenic variants can cause quantitative or qualitative fibrinogen disorders and, in some alleles, hereditary renal amyloidosis.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in FGG have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
GNAS: Guanine nucleotide-binding protein G(s) subunit alpha isoforms short
It produces the stimulatory G-alpha subunit that activates adenylyl cyclase downstream of many hormone receptors, with complex tissue-specific imprinting at the locus. Inactivating variants cause pseudohypoparathyroidism-spectrum disorders, while activating somatic variants cause McCune-Albright syndrome and some endocrine tumors.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GNAS have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
PHF6: PHD finger protein 6
It participates in chromatin regulation, transcription, and ribosome biogenesis during development and hematopoiesis. Germline loss-of-function variants cause Borjeson-Forssman-Lehmann syndrome, while somatic mutations occur recurrently in T-cell leukemia and myeloid malignancies.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PHF6 have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
POLG: DNA polymerase subunit gamma-1
It replicates and repairs mitochondrial DNA and is therefore essential for maintaining mitochondrial genome copy number and integrity. Pathogenic variants cause a broad spectrum including Alpers syndrome, progressive external ophthalmoplegia, epilepsy, ataxia, neuropathy, and liver disease.
0 ClinVar pathogenic / likely pathogenic and 10 uncertain variants in POLG have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
GCH1: GTP cyclohydrolase 1
It catalyzes the rate-limiting step in tetrahydrobiopterin synthesis, supplying an essential cofactor for dopamine, serotonin, norepinephrine, and nitric-oxide production. Dominant loss-of-function variants classically cause dopa-responsive dystonia, while biallelic deficiency can produce severe neurotransmitter disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GCH1 have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
SETX: Helicase senataxin
It resolves RNA-DNA hybrids and supports transcription termination, RNA processing, and genome stability, particularly in long-lived neurons. Different pathogenic mechanisms cause ataxia with oculomotor apraxia type 2 or juvenile amyotrophic lateral sclerosis type 4.
0 ClinVar pathogenic / likely pathogenic and 17 uncertain variants in SETX have source records linked to Hereditary spastic paraplegia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): NSD1, APOA1, GFAP, JAK3, SETBP1, SPTBN2, TBK1 and VCP.
Where Hereditary spastic paraplegia variants cluster
- KIF1A Kinesin motor (positions 5–354): 43 of 44 ClinVar pathogenic / likely pathogenic variants, 4.7× more than its size predicts (a length-based count, not a validated hotspot).
- KIF5A Microtubule-binding (positions 174–315): 23 of 29 ClinVar pathogenic / likely pathogenic variants, 5.8× more than its size predicts (a length-based count, not a validated hotspot).
- ATL1 3HB (three-helix bundle) domain (positions 347–438): 20 of 48 ClinVar pathogenic / likely pathogenic variants, 2.5× more than its size predicts (a length-based count, not a validated hotspot).
- REEP1 Transmembrane (positions 1–21): 6 of 11 ClinVar pathogenic / likely pathogenic variants, 5.2× more than its size predicts (a length-based count, not a validated hotspot).
- KIF5A Necessary for interaction with ZFYVE27 (positions 271–361): 8 of 29 ClinVar pathogenic / likely pathogenic variants, 3.1× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Hereditary spastic paraplegia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SPG7 A510V | 510 | Mitochondrial matrix | Pathogenic / likely pathogenic (★★★★) |
| ATL1 R416C | 416 | Coiled coil | Pathogenic / likely pathogenic (★★★★) |
| KIF1A R11Q | 11 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF1A R11W | 11 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF1A R13H | 13 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF1A R254Q | 254 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF1A R254W | 254 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| ATL1 R415W | 415 | Coiled coil | Pathogenic / likely pathogenic (★★) |
| KIF5A R191H | 191 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF5A R191C | 191 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF5A R204W | 204 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF5A R280H | 280 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| REEP1 A20E | 20 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SPAST R460H | 460 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST R460C | 460 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST R498G | 498 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST R498S | 498 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST R499C | 499 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST G559D | 559 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST R562Q | 562 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPG7 G666R | 666 | Mitochondrial matrix | Pathogenic / likely pathogenic (★★) |
| ATL1 T156I | 156 | GB1/RHD3-type G | Pathogenic / likely pathogenic (★★) |
| ATL1 T156P | 156 | GB1/RHD3-type G | Pathogenic / likely pathogenic (★★) |
| ATL1 R239L | 239 | GB1/RHD3-type G | Pathogenic / likely pathogenic (★★) |
| ATL1 M408T | 408 | 3HB (three-helix bundle) domain | Pathogenic / likely pathogenic (★★) |
| KIF1A R13C | 13 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF1A G102S | 102 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF1A R167C | 167 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF1A E253K | 253 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF1A P305L | 305 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF1A R350W | 350 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF5A R204Q | 204 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF5A L233P | 233 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| KIF5A R280C | 280 | Kinesin motor | Pathogenic / likely pathogenic (★★) |
| REEP1 P19L | 19 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| REEP1 P19R | 19 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SPAST E356K | 356 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST L371R | 371 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST L371F | 371 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST P384L | 384 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST P384R | 384 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST N386S | 386 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST K388N | 388 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST T389A | 389 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST M390I | 390 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST S407N | 407 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST A409T | 409 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST G417E | 417 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST G417V | 417 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST R424T | 424 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST L426F | 426 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST L426V | 426 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST D441G | 441 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST R450K | 450 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST R450G | 450 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST E454K | 454 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST T486I | 486 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST T486A | 486 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST A495V | 495 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
| SPAST R498M | 498 | Sufficient for microtubule severing | Pathogenic / likely pathogenic (★★) |
Showing 60 of 336.
Uncertain variants prioritized for review in Hereditary spastic paraplegia
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| REEP1 P19T | 19 | Transmembrane | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; P19L at the same position is pathogenic; REVEL 0.983 |
| SPAST P509L | 509 | Sufficient for microtubule severing | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; P509S at the same position is pathogenic; REVEL 0.924 |
| REEP1 A20T | 20 | Transmembrane | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; A20P at the same position is pathogenic; REVEL 0.907 |
| SPG7 G577D | 577 | Mitochondrial matrix | Conflicting reports (★) | +6: G577S at the same position is pathogenic; REVEL 0.950 |
| SPAST R503Q | 503 | Sufficient for microtubule severing | Conflicting reports (★) | +6: in a 3D region that tolerates change poorly (3A); R503W at the same position is pathogenic; REVEL 0.882 |
| SPG7 G577A | 577 | Mitochondrial matrix | Conflicting reports (★) | +6: G577S at the same position is pathogenic; REVEL 0.941 |
| SPG7 A647V | 647 | Mitochondrial matrix | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; A647E at the same position is pathogenic; REVEL 0.918 |
| SPG7 D650N | 650 | Mitochondrial matrix | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; D650Y at the same position is pathogenic; REVEL 0.853 |
| SPG7 A647S | 647 | Mitochondrial matrix | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; A647E at the same position is pathogenic; REVEL 0.804 |
| SPAST R499S | 499 | Sufficient for microtubule severing | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; R499L at the same position is pathogenic; REVEL 0.954 |
| SPAST P509T | 509 | Sufficient for microtubule severing | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; P509S at the same position is pathogenic; REVEL 0.952 |
| SPG7 G349V | 349 | Mitochondrial matrix | Uncertain (★★) | +6: G349S at the same position is pathogenic; REVEL 0.943 |
| REEP1 L59P | 59 | Transmembrane | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; L59H at the same position is pathogenic; REVEL 0.938 |
Which prediction tools work for Hereditary spastic paraplegia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaGenome (regulatory): 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 96 out of 100
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 96 out of 100
- CADD: 94 out of 100
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 90 out of 100
- SIFT: 85 out of 100
- phyloP: 80 out of 100
- AlphaGenome (splicing): 76 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 56 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 28 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Pelizaeus-Merzbacher disease also has ClinVar records linked to PLP1 variants; they fall mostly in different places as the Hereditary spastic paraplegia variants (51 pathogenic / likely pathogenic).
Diseases related to Hereditary spastic paraplegia
- Amyotrophic lateral sclerosis, also linked to KIF5A and SETX
- Neuropathy, hereditary sensory, also linked to ATL1 and KIF1A
- Auditory neuropathy, also linked to KIF5A and PLP1
- Possible mitochondrial disorder - nuclear genes, also linked to POLG and SPG7
- Mitochondrial disease, also linked to POLG and SPG7
- Spastic ataxia, also linked to SETX and SPG7
- Mitochondrial DNA maintenance disorder, also linked to POLG and SPG7
- Hereditary ataxia, also linked to SPAST and SPG7
- Hypertrophic cardiomyopathy, also linked to FGG
- Charcot-Marie-Tooth disease, also linked to KIF5A
- Noonan syndrome, also linked to FGG
- Limb-girdle muscular dystrophy, also linked to L1CAM
Frequently asked questions
Which genes have records linked to Hereditary spastic paraplegia?
This view contains 15 analyzed proteins: SPAST, ATL1, KIF1A, KIF5A, SPG7 and 10 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 336 pathogenic or likely pathogenic variants, 1,818 variants of uncertain significance and 379 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 13 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 2,972 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center